| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
|
|
2003
|
|
1S |
p. S1-S153
|
artikel
|
| 2 |
A double-blind pilot study of the effect of Prokarin™ on fatigue in multiple sclerosis
|
Gillson, G.
|
|
2002
|
|
1S |
p. 30-35
|
artikel
|
| 3 |
Aetiology of MS
|
|
|
1998
|
|
1S |
p. S3-S4
|
artikel
|
| 4 |
A pilot study of recombinant insulin-like growth factor-I in seven multiple sclerosis patients
|
Frank, JA
|
|
2002
|
|
1S |
p. 24-29
|
artikel
|
| 5 |
Axons
|
|
|
1998
|
|
1S |
p. S38-S38
|
artikel
|
| 6 |
Blood Brain Barrier
|
|
|
1998
|
|
1S |
p. S28-S29
|
artikel
|
| 7 |
Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-la (AVONEX®) therapy
|
Reeß, J.
|
|
2002
|
|
1S |
p. 15-18
|
artikel
|
| 8 |
Cervical cord atrophy assessment on magnetic resonance imaging: PROMiSe trial
|
Li, David
|
|
2004
|
|
1S |
p. S79-S80
|
artikel
|
| 9 |
Communication
|
|
|
1998
|
|
1S |
p. S49-S50
|
artikel
|
| 10 |
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
|
Rovaris, M.
|
|
2002
|
|
1S |
p. 52-58
|
artikel
|
| 11 |
Ectrims and Actrims '99 Lecture
|
|
|
1999
|
|
1S |
p. S1-S106
|
artikel
|
| 12 |
Editorial
|
Wolinsky, Jerry S
|
|
2004
|
|
1S |
p. S1-S1
|
artikel
|
| 13 |
Effect of drugs in secondary disease progression in patients with multiple sclerosis
|
Kappos, Ludwig
|
|
2004
|
|
1S |
p. S46-S55
|
artikel
|
| 14 |
Epidemiology
|
|
|
1998
|
|
1S |
p. S46-S46
|
artikel
|
| 15 |
Frontiers in Multiple Sclerosis
|
|
|
1998
|
|
1S |
p. S1-S1
|
artikel
|
| 16 |
Gene Therapy
|
|
|
1998
|
|
1S |
p. S5-S6
|
artikel
|
| 17 |
Genetics
|
|
|
1998
|
|
1S |
p. S33-S34
|
artikel
|
| 18 |
Glia
|
|
|
1998
|
|
1S |
p. S36-S37
|
artikel
|
| 19 |
Health Assessment
|
|
|
1998
|
|
1S |
p. S41-S42
|
artikel
|
| 20 |
High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study
|
Casanova, B.
|
|
2002
|
|
1S |
p. 59-63
|
artikel
|
| 21 |
Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques
|
Filippi, Massimo
|
|
2004
|
|
1S |
p. S36-S45
|
artikel
|
| 22 |
Immunological aspects of secondary progressive multiple sclerosis
|
Weiner, LP
|
|
2002
|
|
1S |
p. 83-84
|
artikel
|
| 23 |
Immunologic factors in primary progressive multiple sclerosis
|
Hohlfeld, Reinhard
|
|
2004
|
|
1S |
p. S16-S22
|
artikel
|
| 24 |
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis
|
van der Meijs, Ahc
|
|
2002
|
|
1S |
p. 64-67
|
artikel
|
| 25 |
International consensus statement on the use of disease-modifying agents in multiple sclerosis
|
Freedman, MS
|
|
2002
|
|
1S |
p. 19-23
|
artikel
|
| 26 |
John N Whitaker, MD
|
|
|
2002
|
|
1S |
p. 1-1
|
artikel
|
| 27 |
Keynote Speakers
|
|
|
2001
|
|
1S |
p. S1-S7
|
artikel
|
| 28 |
Late Breakers
|
|
|
2001
|
|
1S |
p. S129-S129
|
artikel
|
| 29 |
Minimal and Moderate Impairment
|
|
|
1998
|
|
1S |
p. S16-S17
|
artikel
|
| 30 |
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis
|
Stüve, Olaf
|
|
2004
|
|
1S |
p. S58-S61
|
artikel
|
| 31 |
Model Systems I
|
|
|
1998
|
|
1S |
p. S9-S10
|
artikel
|
| 32 |
Model Systems II
|
|
|
1998
|
|
1S |
p. S11-S12
|
artikel
|
| 33 |
Mri
|
|
|
1998
|
|
1S |
p. S30-S32
|
artikel
|
| 34 |
MRI aspects of secondary progressive multiple sclerosis
|
Wolinsky, JS
|
|
2002
|
|
1S |
p. 85-87
|
artikel
|
| 35 |
MS: Frontiers in Patient Care and Disease Management Platform Presentations
|
|
|
1998
|
|
1S |
p. S14-S15
|
artikel
|
| 36 |
MS: Frontiers in Science & Joint Sessions Platform Presentations
|
|
|
1998
|
|
1S |
p. S2-S2
|
artikel
|
| 37 |
MS: Frontiers in Science & Patient Care and Disease Management Posters on Display Immunology
|
|
|
1998
|
|
1S |
p. S25-S27
|
artikel
|
| 38 |
MS: Frontiers in Science Platform Poster Presentations (These posters are also on display)
|
|
|
1998
|
|
1S |
p. S22-S24
|
artikel
|
| 39 |
Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis
|
Narayana, Ponnada A
|
|
2004
|
|
1S |
p. S73-S78
|
artikel
|
| 40 |
Multidisciplinary Services
|
|
|
1998
|
|
1S |
p. S43-S45
|
artikel
|
| 41 |
Natural history of primary progressive multiple sclerosis
|
Ebers, George C
|
|
2004
|
|
1S |
p. S8-S15
|
artikel
|
| 42 |
On the horizon: possible neuroprotective role for glatiramer acetate
|
Kreitman, Rivka Riven
|
|
2004
|
|
1S |
p. S81-S89
|
artikel
|
| 43 |
Oral Abstracts
|
|
|
1999
|
|
1S |
p. S127-S144
|
artikel
|
| 44 |
Overview of European pilot study of interferon β-1b in primary progressive multiple sclerosis
|
Montalban, Xavier
|
|
2004
|
|
1S |
p. S62-S64
|
artikel
|
| 45 |
Overview of London trial of intramuscular interferon-β1a in primary progressive multiple sclerosis
|
Miller, David H
|
|
2004
|
|
1S |
p. S56-S57
|
artikel
|
| 46 |
Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis
|
Thompson, Alan
|
|
2004
|
|
1S |
p. S2-S7
|
artikel
|
| 47 |
Palliative and Terminal Care
|
|
|
1998
|
|
1S |
p. S20-S21
|
artikel
|
| 48 |
Platform Presentations
|
|
|
2002
|
|
1S |
p. 73-80
|
artikel
|
| 49 |
Platform Presentations
|
|
|
2001
|
|
1S |
p. S8-S17
|
artikel
|
| 50 |
Poster abstracts
|
|
|
2000
|
|
1S |
p. S38-S50
|
artikel
|
| 51 |
Poster Abstracts
|
|
|
2001
|
|
1S |
p. S18-S128
|
artikel
|
| 52 |
PPMS Roundtable Discussion
|
Wolinsky, Jerry
|
|
2004
|
|
1S |
p. S90-S96
|
artikel
|
| 53 |
Primary progressive multiple sclerosis: cerebrospinal fluid considerations
|
Freedman, Mark S
|
|
2004
|
|
1S |
p. S31-S35
|
artikel
|
| 54 |
Randomized, double-blind, placebo-controlled study of subcutaneous interferon beta-Ia in relapsing-remitting multiple sclerosis: a categorical disability trend analysis
|
Liu, C.
|
|
2002
|
|
1S |
p. 10-14
|
artikel
|
| 55 |
Rehabilitation
|
|
|
1998
|
|
1S |
p. S47-S48
|
artikel
|
| 56 |
Research Meets Care
|
|
|
1998
|
|
1S |
p. S13-S13
|
artikel
|
| 57 |
Severe Disability
|
|
|
1998
|
|
1S |
p. S18-S19
|
artikel
|
| 58 |
Speaker abstracts
|
|
|
2000
|
|
1S |
p. S1-S37
|
artikel
|
| 59 |
The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
|
McFarland, HF
|
|
2002
|
|
1S |
p. 71-72
|
artikel
|
| 60 |
The interdisciplinary approach to the treatment of multiple sclerosis patients in Italy: an aspiration or a reality?
|
Uccelli, M Messmer
|
|
2002
|
|
1S |
p. 36-39
|
artikel
|
| 61 |
The natural history of secondary progressive multiple sclerosis: observations from the London study group
|
Rice, Gpa
|
|
2002
|
|
1S |
p. 81-82
|
artikel
|
| 62 |
The pathology of primary progressive multiple sclerosis
|
Lucchinetti, Claudia
|
|
2004
|
|
1S |
p. S23-S30
|
artikel
|
| 63 |
The PROMiSe trial: baseline data review and progress report
|
Wolinsky, Jerry S
|
|
2004
|
|
1S |
p. S65-S72
|
artikel
|
| 64 |
Therapeutic approaches to secondary progressive multiple sclerosis
|
Lublin, FD
|
|
2002
|
|
1S |
p. 88-90
|
artikel
|
| 65 |
The role of MRI as a surrogate outcome measure in multiple sclerosis
|
McFarland, HF
|
|
2002
|
|
1S |
p. 40-51
|
artikel
|
| 66 |
Treating Symptoms
|
|
|
1998
|
|
1S |
p. S7-S8
|
artikel
|
| 67 |
Treatment
|
|
|
1998
|
|
1S |
p. S39-S40
|
artikel
|
| 68 |
Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response
|
Coyle, PK
|
|
2002
|
|
1S |
p. 2-9
|
artikel
|
| 69 |
Virus
|
|
|
1998
|
|
1S |
p. S35-S35
|
artikel
|
Tijdschrift beschrijving